Results 121 to 130 of about 27,038 (199)

Targeting Leishmania donovani Sphingosine Kinase 1 using PF-543 enhances immune response and limits parasite load. [PDF]

PLoS Negl Trop Dis
Madan E, Bansal R, Singhal J, Joshi N, Saini M, Shafi S, Gupta A, Singh S.   +7 more
europepmc   +1 more source

Molecular docking analysis of sphingosine kinase 1 inhibitors for cancer management. [PDF]

Bioinformation, 2023
Barnawi J.
europepmc   +1 more source

Corrigendum to "Isoflurane versus sevoflurane for early brain injury and expression of sphingosine kinase 1 after experimental subarachnoid hemorrhage" [Neurosci. Lett. 733 (2020) 135142]. [PDF]

Neurosci Lett
Altay O, Suzuki H, Altay BN, Calisir V, Tang J, Zhang JH.   +5 more
europepmc   +1 more source

Sphingosine kinase 1 is involved in triglyceride breakdown by maintaining lysosomal integrity in brown adipocytes. [PDF]

J Lipid Res, 2023
Morishige JI, Yoshioka K, Nakata H, Ishimaru K, Nagata N, Tanaka T, Takuwa Y, Ando H.   +7 more
europepmc   +1 more source

Sphingosine kinase 2 suppresses neutrophil responses to promote viral persistence while attenuating immune pathology. [PDF]

Front Immunol
Vijayamahantesh V, He Y, Jiang L, Huerter H, Jung KI, McKenna S, Studstill CJ, Allen LH, Nistala R, Xu D, Hahm B.   +10 more
europepmc   +1 more source

miR-205 Enhances Sensitivity to Genotoxic Agents in HNSCC Cells and Blocks Sphingosine Kinase 2 Action in Tumorigenicity. [PDF]

ACS Omega
Milan TM, da Silva G, de Sousa GR, Leopoldino AM.   +3 more
europepmc   +1 more source

Sphingosine Kinase 1 - A Therapeutic Opportunity for Alleviating Liver Fibrosis? [PDF]

Cell Mol Gastroenterol Hepatol
Teo JMN, Ling GS.
europepmc   +1 more source

Discovery of Sphingosine Kinase Inhibition by Modified Quinoline-5,8-Diones. [PDF]

Pharmaceuticals (Basel)
Kruschel RD, Malone K, Walsh AN, Waeber C, McCarthy FO.   +4 more
europepmc   +1 more source

Upregulated <i>BLM</i> and <i>RECQL4</i> in Osteosarcoma: Association with Poor Prognosis, Immune Cell Infiltration, and Inhibitory Effects of Sphingosine Kinase 1 Inhibitor II/Pilaralisib. [PDF]

Immunotargets Ther
Chen J, Situ Y, Cai J, Liao W, Jiang D, Huang C, Zheng J, Peng L, Lin H.   +8 more
europepmc   +1 more source

Exploring anticancer activity of baicalin, naringenin, and noscapine via binding and inhibition of sphingosine kinase 1. [PDF]

3 Biotech
Shakeel I, Mohammad T, Haider S, Hussain A, AlAjmi MF, Chakrabarty A, Sohal SS, Afzal M, Hassan MI.   +8 more
europepmc   +1 more source